Quercetin-induced apoptosis in colorectal tumor cells: Possible role of EGF receptor signaling

Nutrition and Cancer

Volumn 34, Issue 1, 1999, Pages 88-99

  Richter, Marion ^a   Ebermann, Robert ^b   Marian, Brigitte ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; FISETIN; FLAVONOID; KAEMPFEROL; MYRICETIN; QUERCETIN;

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL LOSS; COLORECTAL TUMOR; CONTROLLED STUDY; DIETARY INTAKE; ENZYME INHIBITION; FRUIT; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; VEGETABLE;

EID: 0032863640     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC340113     Document Type: Article

References (43)

1. Hertog, MG, Hollman, PC, Katan, MB, and Kromhout, D: Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 20, 21-29, 1993.
2. Vogel, VG, and McPherson, RS: Dietary epidemiology of colon cancer. Hematol Oncol Clin North Am 3, 35-63, 1989.
3. Herrmann, K: On the occurrence of flavonol and flavone glycosides in vegetable. Z Lebensm Unters Forsch 186, 1-5, 1988.
4. Kuhnau, J: The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 24, 117-191, 1976.
5. Deschner, EE, Ruperto, J, Wong, G, and Newmark, HL: Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 12, 1193-1196, 1991.
6. Deschner, EE, Ruperto, JF, Wong, GY, and Newmark, HL: The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr Cancer 20, 199-204, 1993.
7. Kawamori, T, Tanaka, T, Hara, A, Yamahara, J, and Mori, H: Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Cancer Res 55, 1277-1282, 1995.
8. Duthie, SJ, Johnson, W, and Dobson, VL: The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimidines) and growth in human cells. Mutat Res Genet Toxicol Environ Mutagenesis 390, 141-151, 1997.
9. Castillo, MH, Perkins, E, Campbell, JH, Doerr, R, Hassett, JM, et al.: The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. Am J Surg 158, 351-355, 1989.
10. Agullo, G, Gamet, L, Besson, C, Demigne, C, and Remesy, C: Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma HT29 and Caco-2 cells. Cancer Lett 87, 55-63, 1994.
11. Kaur, G, Stetler Stevenson, M, Sebers, S, Worland, P, Sedlacek, H, et al.: Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. JNCI 84, 1736-1740, 1992.
12. Kuo, SM: Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 110, 41-48, 1996.
13. Scambia, G, Ranelletti, FO, Benedetti Panici, P, Piantelli, M, Bonanno, G, et al.: Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites. Cancer Chemother Pharmacol 28, 255-258, 1991.
14. Wei, YQ, Zhao, X, Kariya, Y, Fukata, H, Teshigawara, K, et al.: Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res 54, 4952-4957, 1994.
15. Corvazier, E, and Maclouf, J: Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. Biochim Biophys Acta 835, 315-321, 1985.
16. Akayama, T, Ishida, J, Nakagawa, S, Ogawara, H, Watanabe, S, et al.: Genistein, a specific inhibitor of tyrosine-specific kinases. J Biol Chem 262, 5592-5595, 1987.
17. Ferriola, PC, Cody, V, and Middleton, E, Jr: Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38, 1617-1624, 1989.
18. Losiewicz, MD, Carlson, BA, Kaur, G, Sausville, EA, and Worland, PJ: Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275. Biochem Biophys Res Commun 201, 589-595, 1994.
19. Nishizawa, Y, Nishii, K, Kishimoto, S, Matsumoto, K, and Sato, B: Regulatory role of arachidonic acid-derived metabolites for proliferation of transformed murine Leydig cell in serum-free culture condition. Anticancer Res 10, 317-322, 1990.
20. Singhal, RL, Yeh, YA, Praja, N, Olah, E, Sledge, GW, Jr, et al.: Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun 208, 425-431, 1995.
21. Ursini, F, Maiorino, M, Morazzoni, P, Roveri, A, and Pifferi, G: A novel antioxidant flavonoid (IdB 1031) affecting molecular mechanisms of cellular activation. Free Radic Biol Med 16, 547-553, 1994.
22. Plaumann, B, Fritsche, M, Rimpler, H, Brandner, G, and Hess, RD: Flavonoids activate wild-type p53. Oncogene 13, 1605-1614, 1996.
23. Csokay, B, Prajda, N, Weber, G, and Olah, E: Molecular mechanisms in the antiproliferative action of quercetin. Life Sci 60, 2157-2163, 1997.
24. Kuo, ML, and Yang, NC: Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. Biochem Biophys Res Commun 212, 767-775, 1995.
25. Pagliacci, MC, Smacchia, M, Migliorati, G, Grignani, F, Riccardi, C, et al.: Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer 30A, 1675-1682, 1994.
26. Willson, JK, Bittner, GN, Oberley, TD, Meisner, LF, and Weese, JL: Cell culture of human colon adenomas and carcinomas. Cancer Res 47, 2704-2713, 1987.
27. Coffey, RJ, Jr, Goustin, AS, Soderquist, AM, Shipley, GD, Wolfshohl, J, et al.: Transforming growth factor-α and -β expression in human colon cancer lines: implications for an autocrine model. Cancer Res 47, 4590-4594, 1987.
28. Wu, X, Fan, Z, Masui, H, Rosen, N, and Mendelsohn, J: Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest 95, 1897-1905, 1995.
29. Partik, G, Hochegger, K, Schörkhuber, M, and Marian, B: Inhibition of EGF receptor-dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro. J Cancer Res Clin Oncol. In press.
30. Schörkhuber, M, Karner-Hanusch, J, Sediviy, R, Ellinger, A, Armbruster, C, et al.: Survival of normal colonic epithelial cells from both rats and humans is prolonged by coculture with rat embryo colonic fibroblasts. Cell Biol Toxicol 14, 211-223, 1998.
31. r 63,000 protein induced by an endogenous mitogen in human colon carcinoma cells, but not in normal colonocytes. Cancer Res 49, 4231-4236, 1989.
32. Lee, H, Ghose Dastidar, J, Winawer, S, and Friedman, E: Signal transduction through extracellular signal-regulated kinase-like pp57 blocked in differentiated cells having low protein kinase C-β activity. J Biol Chem 268, 5255-5263, 1993.
33. Agullo, G, Gamet Payrastre, L, Fernandez, Y, Anciaux, N, Demigne, C, et al.: Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells). Cancer Lett 105, 61-70, 1996.
34. Karnes, WE, Jr, Walsh, JH, Wu, SV, Kim, RS, Martin, MG, et al.: Autonomous proliferation of colon cancer cells that coexpress transforming growth factor-α and its receptor. Variable effects of receptor-blocking antibody. Gastroenterology 102, 474-485, 1992.
35. Koide, T, Kamei, H, Hashimoto, Y, Kojima, T, Terabe, K, et al.: Influence of flavonoids on cell cycle phase as analyzed by flow cytometry. Cancer Biother Radiopharm 12, 111-115, 1997
36. 2/M arrest in keratinocytes. Carcinogenesis 17, 2367-2375, 1996.
37. Lepley, DM, and Pelling, JC: Induction of P21/Wafl and G(1) cell cycle arrest by the chemopreventive agent apigenin. Mol Carcinog 19, 74-82, 1997.
38. 1 phase of the cell cycle. Cancer Res 52, 6676-6681, 1992.
39. Yoshida, M, Sakai, T, Hosokawa, N, Marui, N, Matsumoto, K, et al.: The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260, 10-13, 1990.
40. Hosokawa, N, Hosokawa, Y, Sakai, T, Yoshida, M, Marui, N, et al.: Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-kDa protein, in human colon cancer cells. Int J Cancer 45, 1119-1124, 1990.
41. Hollman, PCH, Vantrijp, JMP, Mengelers, MJB, Devries, JHM, and Katan, MB: Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett 114, 139-140, 1997.
42. Middleton, E, Jr, and Kandaswami, C: The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In The Flavonoids, Advances in Research Since 1986, JB Harborne (ed). London: Chapman & Hall, 1993, pp 619-652.
43. Manach, C, Morand, C, Texier, O, Favier, ML, Agullo, G, et al.: Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J Nutr 125, 1911-1922, 1995.